Endothelial dysfunction: Associations with exposure to ambient fine particles in diabetic individuals

Environmental Health Perspectives

Volumn 116, Issue 12, 2008, Pages 1666-1674

  Schneider, Alexandra ^a   Neas, Lucas ^b   Herbst, Margaret C ^c   Case, Martin ^b   Williams, Ronald W ^d   Cascio, Wayne ^e   Hinderliter, Alan ^c   Holguln, Fernando ^f   Buse, John B ^c   Dungan, Kathleen ^g   Styner, Maya ^c   Peters, Annette ^a   Devlin, Robert B ^b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^e EAST CAROLINA UNIVERSITY   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g OHIO STATE UNIVERSITY   (United States)

Author keywords

Air pollution; Diabetes; Endothelial dysfunction; Environmental epidemiology; Particulate matter

Indexed keywords

ADIPONECTIN; GLUTATHIONE TRANSFERASE M1; HEMOGLOBIN A1C; MYELOPEROXIDASE;

ADULT; AGED; AIR MONITORING; AIR POLLUTANT; AIR POLLUTION; ARTERY COMPLIANCE; ARTICLE; BODY MASS; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; METEOROLOGICAL PHENOMENA; MONITORING; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTICULATE MATTER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE; SEASON; UNITED STATES; VOLUNTEER; ANIMAL; DRUG EFFECT; MIDDLE AGED; PARTICLE SIZE; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

AGED, 80 AND OVER; AIR POLLUTANTS; ANIMALS; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; NORTH CAROLINA; PARTICLE SIZE;

EID: 58149332676     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.11666     Document Type: Article

References (71)

1. Beckman JA, Creager MA, Libby P. 2002. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287:2570-2581.
2. Bonetti PO, Lerman LO, Lerman A. 2003. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 23:168-175.
3. Bouthillier L, Vincent R, Goegan P, Adamson IY, Bjarnson S, Stewart M, et al. 1998. Acute effects of inhaled urban particles and ozone: lung morphology, macrophage activity, and plasma endothlein-1. Am J Pathol 153:1873-1884.
4. Briet M, Collin C, Laurent S, Tan A, Azizi M, Agharazii M, et al. 2007. Endothelial function and chronic exposure to air pollution in normal male subjects. Hypertension 50:970-976.
5. Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, Silverman F. 2002. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation 105:1534-1536.
6. Caballero AE. 2003. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes Res 11:1278-1289.
7. Calles-Escandon J, Cipolla M. 2001. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 22:36-52.
8. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. 1994. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 24:1468-1474.
9. Cohen JD. 2007. Overview of physiology, vascular biology, and mechanisms of hypertension. J Manag Care Pharm 13:S6-S8.
10. Cohn JN, Finkelstein SM, McVeigh G, Morgan D, LeMay L, Robinson J, et al. 1995. Noninvasive pulse wave analysis for the early detection of vascular disease. Hypertension 26:503-508.
11. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. 2002. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257-265.
12. Creager MA, Luscher TF, Cosentino F, Beckman JA. 2003. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation 108:1527-1532.
13. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. 2000. Endothelial dysfunction in diabetes. Br J Pharmacol 130:963-974.
14. Donaldson K, Tran L, Jimenez LA, Duffin R, Newby DE, Mills N, et al. 2005. Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part Fibre Toxicol 2:10.
15. Eiserich JP, Baldus S, Brennan ML, Ma W, Zhang C, Tousson A, et al. 2002. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296:2391-2394.
16. Feder JN, Penny DM, Irrinki A, Lee VK, Lebron JA, Watson N, et al. 1998. The hemochromatosis gene product complexes with the transferring receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 95:1472-1477.
17. Feener EP, King GL. 2001. Endothelial dysfunction in diabetes mellitus: role in cardiovascular disease. Heart Fail Monit 1:74-82.
18. Finkelstein SM, Cohn JN. 1992. First- and third-order models for determining arterial compliance. J Hypertens Suppl 10:S11-S14.
19. Flanagan PR, Haist J, Valberg LS. 1980. Comparative effects of iron deficiency induced by bleeding and low-iron diet on the intestinal absorptive interactions of iron, cobalt, manganese, zinc, lead and cadmium. J Nutr 110:1754-1763.
20. Ganz P, Vita JA. 2003. Testing endothelial vasomotor function: nitric oxide, a multipotent molecule. Circulation 108:2049-2053.
21. Gilliland FD, Gauderman WJ, Vora H, Rappaport E, Dubeau L. 2002. Effects of glutathione-S-transferase M1, T1, and P1 on childhood lung function growth. Am J Respir Crit Care Med 166:710-716.
22. Gilliland FD, Li YF, Gong H, Diaz-Sanchez D. 2006. Glutathione S-transferases M1 and P1 prevent aggravation of allergic responses by secondhand smoke. Am J Respir Crit Care Med 174:1335-1341.
23. Gilliland FD, Li YF, Saxon A, Diaz-Sanchez D. 2004. Effect of glutathione- S-transferase M1 and P1 genotypes on xenobiotic enhancement of allergic responses: randomised, placebo-controlled crossover study. Lancet 363:119-125.
24. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Menzoian JO, Vita JA. 2002. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 105:1567-1572.
25. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, et al. 2003. Predictive value of noninvasively determined endothelial dysfunction for longterm cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 41:1769-1775.
26. Goldberg MS, Burnett RT, Yale JF, Valois MF, Brook JR. 2006. Associations between ambient air pollution and daily mortality among persons with diabetes and cardiovascular disease. Environ Res 100:255-267.
27. Greven S, Küchenhoff H, Peters A. 2006. Additive mixed models with P-splines. In: Proceedings of the 21st International Workshop on Statistical Modelling, July 3-7 2006, Galway, Ireland (Hinde J, Einbeck J, Newell J, eds). Lancaster, UK:University of Lancaster, 201-207.
28. Grey E, Bratelli C, Glasser SP, Alinder C, Finkelstein SM, Lindgren BR, et al. 2003. Reduced small artery but not large artery elasticity is an independent risk marker for cardiovascular events. Am J Hypertens 16:265-269.
29. Hanson EH, Imperatore G, Burke W. 2001. HFE gene and hereditary hemochromatosis: a HuGE review. Am J Epidemiol 154:193-206.
30. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. 2001. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104:2673-2678.
31. Holay MP, Paunikar NP, Joshi PP, Sahasrabhojney VS, Tankhiwale SR. 2004. Effect of passive smoking on endothelial function in: healthy adults. J Assoc Physicians India 52:114-117.
32. Howard G, Wagenknecht LE. 1999. Environmental tobacco smoke and measures of subclinical vascular disease. Environ Health Perspect 107(suppl 6):837-840.
33. Hsueh WA, Lyon CJ, Quinones MJ. 2004. Insulin resistance and the endothelium. Am J Med 117:109-117.
34. Hsueh WA, Quinones MJ. 2003. Role of endothelial dysfunction in insulin resistance. Am J Cardiol 92:10J-17J.
35. Kardasz I, De Caterina R. 2007. Myocardial infarction with normal coronary arteries: a conundrum with multiple aetiologies and variable prognosis: an update. J Intern Med 261:330-348.
36. Kato T, Inoue T, Morooka T, Yoshimoto N, Node K. 2006. Short-term passive smoking causes endothelial dysfunction via oxidative stress in nonsmokers. Can J Physiol Pharmacol 84:523-529.
37. Libby P, Ridker PM, Maseri A. 2002. Inflammation and atherosclerosis. Circulation 105:1135-1143.
38. Mahmoudi M, Curzen N, Gallagher PJ. 2007. Atherogenesis: the role of inflammation and infection. Histopathology 50:535-546.
39. Maritim AC, Sanders RA, Watkins JB III. 2003. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17:24-38.
40. Mills NL, Törnquist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, et al. 2005. Diesel exhaust inhalation causes vasculoar dysfunction and impaired endogeneous fibrinolysis. Circulation 112:3930-3936.
41. Muller JE, Abela GS, Nesto RW, Tofler GH. 1994. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. J Am Coll Cardiol 23:809-813.
42. Nemmar A, Hoet PH, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, et al. 2002. Passage of inhaled particles into the blood circulation in humans. Circulation 105:411-414.
43. Nemmar A, Hoylaerts MF, Hoet PH, Nemery B. 2004. Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects. Toxicol Lett 149:243-253.
44. Nicholls SJ, Hazen SL. 2005. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 25:1102-1111.
45. O'Neill MS, Veves A, Sarnat JA, Zanobetti A, Gold DR, Economides PA, et al. 2007. Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility. Occup Environ Med 64:373-379.
46. O'Neill MS, Veves A, Zanobetti A, Sarnat JA, Gold DR, Economides PA, et al. 2005. Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation 111:2913-2920.
47. O'Rourke MF, Gallagher DE. 1996. Pulse wave analysis. J Hypertens Suppl 14:S147-S157.
48. Park SK, O'Neill MS, Wright RO, Hu H, Vokonas PS, Sparrow D, et al. 2006. HFE genotype, particulate air pollution, and heart rate variability: a gene-environment interaction. Circulation 114:2798-2805.
49. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, et al. 2001. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 104:191-196.
50. Pope CA III, Dockery DW. 2006. Health effects of fine particulate air pollution: lines that connect. J Air Waste Manag Assoc 56:709-742.
51. Quyyumi AA. 1998. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 105:32S-39S.
52. Romieu I, Ramirez-Aguilar M, Sienra-Monge JJ, Moreno-Macias H, Rio-Navarro BE, David G, et al. 2006. GSTM1 and GSTP1 and respiratory health in asthmatic children exposed to ozone. Eur Respir J 28:953-959.
53. Romieu I, Sienra-Monge JJ, Ramirez-Aguilar M, Moreno-Macias H, Reyes-Ruiz NI, Estela Estela del Rio-Navarro B, et al. 2004. Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City. Thorax 59:8-10.
54. Ross R. 1999. Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126.
55. Rudolph V, Steven D, Gehling UM, Goldmann B, Rudolph TK, Friedrichs K, et al. 2006. Coronary plaque injury triggers neutrophil activation in patients with coronary artery disease. Free Radic Biol Med 42:460-465.
56. Rundell KW, Hoffman JR, Caviston R, Bulbulian R, Hollenbach AM. 2007. Inhalation of ultrafine and fine particulate matter disrupts systemic vascular function. Inhal Toxicol 19:133-140.
57. Salam MT, Lin PC, Avol EL, Gaudermann J, Gilliland FD. 2007. Microsomal epoxide hydrolse, glutathione S-transferase P1, traffic and childhood asthma. Thorax 62:1050-1057.
58. Schram MT, Henry RM, van Dijk RA, Kostense PJ, Dekker JM, Nijpels G, et al. 2004. Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension 43:176-181.
59. Schwartz J, Park SK, O'Neill MS, Vokonas PS, Sparrow D, Weiss S, et al. 2005. Glutathione-S-transferase M1, obesity, statins, and autonomic effects of particles: gene-by-drug-by-environment interaction. Am J Respir Crit Care Med 172:1529-1533.
60. Sorensen KE, Kristensen IB, Celermajer DS. 1997. Atherosclerosis in the human brachial artery. J Am Coll Cardiol 29:318-322.
61. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, et al. 2003. Adiponectin and protection against type 2 diabetes mellitus. Lancet 361:226-228.
62. Stocker R, Keaney JF Jr. 2004. Role of oxidative modifications in atherosclerosis. Physiol Rev 84:1381-1478.
63. Tan KC, Xu A, Chow WS, Lam MC, Ai VH, Tam SC, et al. 2004. Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab 89:765-769.
64. U.S. EPA. 2004. U.S. EPA Air Quality Criteria for Particulate Matter. EPA 600/P-99/002aF-bF. Washington, DC:U.S. Environmental Protection Agency.
65. U.S. EPA (U.S. Environmental Protection Agency). 2006. Federal Register. National ambient air quality standards for particulate matter. Final rule. Fed Reg 71:61144-61233. Available: http://www.epa.gov/ttn/naaqs/ standards/pm/data/fr20061017.pdf [accessed 6 November 2008].
66. Vita JA, Keaney JF Jr. 2002. Endothelial function: a barometer for cardiovascular risk? Circulation 106:640-642.
67. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Berent R, et al. 2004. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 109:184-189.
68. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. 2003. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42:1149-1160.
69. 10 monitors. J Expo Anal Environ Epidemiol 10:497-505.
70. Zanobetti A, Schwartz J. 2001. Are diabetics more susceptible to the health effects of airborne particles? Am J Respir Crit Care Med 164:831-833.
71. Zanobetti A, Schwartz J. 2002. Cardiovascular damage by airborne particles: are diabetics more susceptible? Epidemiology 13:588-592.